Details of the Drug

General Information of Drug (ID: DMI3UD6)

Drug Name

131I-labelled CLR1404

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Radiopharmaceutical therapy agent

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02278315) Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma. U.S. National Institutes of Health.